AlzeCure Hunts For Small Molecules In Its Alzheimer’s Quest

Swedish Biotech Is Developing Broad CNS portfolio

Jul 06 2021

• By Sten Stovall

CEO says potential small-molecule therapies could offer big advantages over biologics • Source: Alamy

More from Clinical Trials

More from R&D